Top News Stories
News
Mayo Clinic launches telehealth access program for new GLP-1 weight-loss drugs
By Alan GoforthShortly after Eli Lilly launched its direct-to-consumer service for its weight loss drug Zepbound, the Mayo Clinic has announced a new telehealth service that will offer direct access to GLP-1 weight-loss medications.










